Abstract
In 1968, The Airlie House Symposium evaluated the current knowledge of the natural history of diabetic retinopathy. The effects of tight metabolic control, pituitary ablation, and photocoagulation were discussed at length. Xenon arc photocoagulation was the mainstay of therapy and was usually applied focally to individual patches of new vessels. Photocoagulation of background retinopathy was rarely done. Panretinal photocoagulation was in its infancy, the ruby laser was newly introduced, there were no data on the use of the argon laser, and automated vitrectomy had not been introduced. Participants in the symposium set the stage for the acquisition of valid clinical data from which important therapeutic conclusions have subsequently been drawn by (1) summarizing the areas of consensus and disagreement, (2) devising a standard classification of diabetic retinopathy, and (3) proposing controlled clinical trials for unanswered questions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
